the intestinal side effects , evaluated by measuring the decrease of marker enzyme ( thymidine kinase , xanthine oxidase , alkaline phosphatase , sucrase , maltase ) activities in isolated enterocytes , were dose-dependent and moderate .
C0021853
intestinal
C0682610
enterocytes